Clinical decision-support only โ€” does not replace attending supervision or institutional policy

Anticoagulation Reversal in Trauma

Rapid identification and reversal of pre-injury anticoagulants โ€” critical in TBI and hemorrhagic trauma.

Educational Reference
Updated: 2024โ€“2025
AnticoagulationWarfarinDOACPCCIdarucizumabAndexanetReversal
On this page3 sections
No local AHS protocol โ€” general educational reference only. Use with attending guidance and institutional policy.
โš ๏ธ General educational reference โ€” no confirmed AHS local reversal protocol. STAT pharmacy/hematology consult required.
โš ๏ธ Always identify the specific anticoagulant before selecting reversal agent.
โš ๏ธ
No local AHS anticoagulation reversal protocol has been uploaded. Use as general educational reference. STAT pharmacy/hematology consult required in all cases.
๐Ÿ’ŠReversal by Agent
โ–ผ
AnticoagulantReversal AgentNotes
Warfarin (Coumadin)4-factor PCC (Kcentra) + IV Vitamin KPCC for rapid reversal (minutes); Vit K for sustained effect (hours). INR goal <1.5 for procedures.
Rivaroxaban (Xarelto)
Apixaban (Eliquis)
Direct Xa inhibitors
Andexanet alfa (Andexxa) OR 4-factor PCCAndexanet alfa is the specific reversal agent. 4-factor PCC is a reasonable alternative if andexanet not available.
Dabigatran (Pradaxa)
Direct thrombin inhibitor
Idarucizumab (Praxbind) 5g IVSpecific monoclonal antibody โ€” highly effective reversal.
Heparin (UFH)Protamine sulfate1mg protamine per 100 units heparin given in last ~2โ€“3h. Give slowly IV.
Enoxaparin (LMWH)Protamine sulfate (partial reversal)1mg protamine per 1mg enoxaparin given in last 8h. ~60% effective.
Antiplatelets (ASA, clopidogrel, ticagrelor)Clinical judgment; platelet transfusion if actively bleedingRoutine platelet transfusion not recommended solely to reverse antiplatelets. Discuss with neurosurgery if TBI.
๐Ÿ”Identifying the Agent
โ–ผ
  • Ask family, EMS, pharmacy โ€” wallet cards, medication bottles
  • Review Epic medication reconciliation if prior AHS/UCSF encounter
  • INR elevated โ†’ warfarin likely; INR normal + active bleeding โ†’ DOAC likely
  • Anti-Xa level confirms heparin, LMWH, or direct Xa inhibitors
  • Prolonged thrombin time (TT) โ†’ dabigatran
  • In TBI emergency: Do not delay reversal waiting to confirm agent โ€” assume anticoagulation and treat
๐Ÿง TBI + Anticoagulation
โ–ผ
  • Time-critical โ€” intracranial bleeding can expand rapidly on anticoagulation
  • Warfarin ICH: 4-factor PCC reverses INR in minutes vs hours for vitamin K alone โ€” use PCC first
  • Serial CT scanning required to assess progression
  • Platelet transfusion for antiplatelet + TBI: discuss with neurosurgery โ€” evidence mixed for clopidogrel
  • Geriatric patients: most common anticoagulation scenario in trauma โ€” prioritize agent identification
Status
General Educational Reference
Source
Popma E et al. JTACS 2025 ยท ACS TBI Best Practices 2024 ยท ACS Geriatric Trauma Guidelines 2023
Last reviewed / updated
2024โ€“2025
Clinical decision-support only โ€” does not replace attending supervision or institutional policy